CHD cases and healthy controls across the CARDIoGRAM Exome Consortium and CHD Exome+ Consortium were genotyped for the SCARB1 P376Lvariant by using the exome array. BioVU, Vanderbilt University Medical Center Biorepository; BHF, British Heart Foundation; GoDARTS-CAD, Genetics of Diabetes and Audit Research Tayside Study; MHI, Montreal Heart Institute; North German, German North Coronary Artery Disease Study; Ottawa, Ottawa Heart Study; PAS, Premature Atherosclerosis Study—Academic Medical Center—Amsterdam; Penn, University of Pennsylvania CHD Cohort; South German, German South Coronary Artery Disease Study; WHI-EA, Women’s Health Initiative—American Cohort; CCHS, Copenhagen City Heart Study; CIHDS/CGPS, gen Ischemic Heart Disease Study/Copenhagen General Population Study; EPIC-CVD, European Prospective Investigation into Cancer and Nutrition— Cardiovascular Disease Study; MORGAM, MOnica Risk, Genetics, Archiving and Monograph Project; PROSPER, Prospective Study of Pravastatin in the Elderly at Risk Study; WOSCOPS, West of Scotland Coronary Prevention Study. The association of the P376L variant with CHD cases was determined using a Mantel-Haenszel fixed-effects Meta-analysis; results were odds ratio = 1.79; P = 0.018.